Market research
LDG.F LiDCO Group Plc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 28M
- P/E ratio
- 22.21
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- -0.03
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- Not available
- Market cap
- 28M
- P/E ratio
- 22.21
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- -0.03
About
About LiDCO Group Plc
LiDCO Group Plc develops, manufactures, and sells hemodynamic monitoring equipment in the United Kingdom, the United States, Continental Europe, and internationally. The company provides LiDCOunity, a hemodynamic monitor to support clinical decision making; LiDCOrapid, a monitor that analyses the blood pressure waveform to provide information in surgical and critically ill patients to help with fluid and drug management; LiDCOview that offers clinical researchers and users with beat-to-beat hemodynamic data; LiDCOplus, a hemodynamic monitor, which provides assessment of the hemodynamic status of critical care and surgery patients; and accessories, including blood pressure modules. It also offers various closed and open pressure monitoring sets for use in the ICU, operating department, and Cath labs; and Stimpod NMS 450X, a quantitative neuromuscular blocking agent monitor. LiDCO Group Plc was founded in 1991 and is headquartered in London, the United Kingdom. As of January 11, 2021, LiDCO Group Plc operates as a subsidiary of Masimo Corporation.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the LDG.F discussion.
5 years, 5 months ago
LiDCO Group Plc is currently in a long term uptrend where the price is trading 62.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.6.
Based on the above factors, LiDCO Group Plc gets an overall score of 2/5.